Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Emerging opportunity in a growing, high-value dermatological market

The following is a transcription of the above video, and The Market Online has edited it for clarity . Kane Biotech Inc. (TSXV:KNE) , a Canadian-based biotech company engaged in the development and commercialization of products that prevent and remove microbial biof...
Ryan Dhillon | April 11, 2024 |

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...
Coreena Robertson | November 6, 2023 |

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...
Brieanna McCutcheon | September 19, 2023 |

Buzz on the Bullboards: Today’s gainers and tomorrow’s winners

Investors dealt with another rate increase from the U.S. Federal Reserve, but could it be the finale for awhile? Time will tell, but many hope this, the 10th straight rate increase reaching its highest point in 16 years, will be enough to help calm unreasonably high ...
Jonathon Brown | May 4, 2023 |

Full Circle Lithium to go public

Full Circle Lithium has strategically positioned itself with a team who has 70-years of experience. Armed with a diversified portfolio of feedstock, Full Circle Lithium has up to 2,000 tonnes of capacity which it plans on filling before expanding. The company also has pro...
Brieanna McCutcheon | May 1, 2023 |

NexOptic: delivers AI solutions that reduce bandwidth

Our next company puts humans first, creating quality artificial intelligence solutions that offer patented solutions for energy savings, data compression and more. In May 2019, AlIIS was born. A machine-learning AI that is giving new life to imaging platforms by giving ac...
Brieanna McCutcheon | March 8, 2023 |

Stronger. Faster. Cheaper. Welcome to the New EV Charging Station

The electric vehicle (EV) revolution is now in full gear, but there still remains a few obstacles to get more buyers into the market – namely EV range anxiety or the fear that their car's battery will die on them mid-trip. Now, there’s a single-source soluti...
Dave Jackson | May 13, 2022 |

Geospatial Data: A New Tech Play “Experiencing High Growth”

You may not know it, but there’s a whole lot more to satellite imagery than Google Earth. New companies with new technology are now entering the market with practical and essential commercial uses of 3D data and models…including flood & wildfire risk modelli...
Dave Jackson | April 22, 2022 |

Unlocking the Healing Potential of Safe, Natural Psychedelics

When we last caught up with Filament Health Corp. ( NEO.FH , Forum ) and their CEO and Co-Founder, Ben Lightburn last July , our Stockhouse investors were introduced to an industry leader in exclusively-natural psychedelic drug discovery and extraction. The company enga...
Dave Jackson | April 11, 2022 |

Buzz on the Bullboards: Six More Weeks of Volatility?

If you haven’t heard, the groundhog saw his shadow, and if the snowfall on the East and West coasts weren’t enough of an indication, it looks like winter may be with us for awhile still … along with COVID and its variants, which are still a...
Stockhouse Editorial | February 2, 2022 |
1 2 3 4 5 6 7